%PDF-1.7
%
%
1 0 obj
<>
endobj
2 0 obj
<>
endobj
3 0 obj
<>
endobj
4 0 obj
<>
endobj
6 0 obj
<>stream
x
endstream
endobj
7 0 obj
<>stream
endstream
endobj
8 0 obj
<>/F2+072ad28c0-6099-4a1c-a3f1-965855bcecdb<>>>/ProcSet[/Text/ImageB/ImageI/ImageC/PDF]>>/Rotate 0/Trans<<>>/Annots[]>>
endobj
9 0 obj
<>stream
q
1 0 0 1 0 0 cm
BT
/F1 12 Tf
14.4 TL
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 531.615 1183.076 Tm
0.086275 0.086275 0.086275 rg
/F2+0 13.5 Tf
16.2 TL
(\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 289.29 1135.575 Tm
0.086275 0.086275 0.086275 rg
/F3+0 27 Tf
32.4 TL
(2016) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 362.955 1135.575 Tm
-0.179 Tc
0.086275 0.086275 0.086275 rg
/F3+0 27 Tf
32.4 TL
(\200\201) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 423.614 1135.575 Tm
-0.054 Tc
0.086275 0.086275 0.086275 rg
/F3+0 27 Tf
32.4 TL
(WHO) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 503.715 1135.575 Tm
0.086275 0.086275 0.086275 rg
/F3+0 27 Tf
32.4 TL
(\202\203\204\205\206\207\210\211\212\213) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 773.789 1135.575 Tm
0.086275 0.086275 0.086275 rg
/F3+0 27 Tf
32.4 TL
(\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 1043.929 Tm
-0.03 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(WHO) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 233.49 1043.929 Tm
-0.091 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\200\201\202\203\204\205\206\207\210\211\212) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 456.375 1043.929 Tm
-0.088 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(2016) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 508.755 1043.929 Tm
-0.091 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\213\214\215) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 569.625 1043.929 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 964.729 Tm
-0.061 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\216\217\220\221\222\206\207) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 317.549 964.729 Tm
-0.068 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040Myeloproliferative\040neoplasm) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 606.704 964.729 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\212) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 626.865 964.729 Tm
-0.04 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(MPN) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 675.465 964.729 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\215) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 695.805 964.729 Tm
-0.08 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 885.529 Tm
-0.078 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\223\222\217\224\225\203\226\227) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 337.755 885.529 Tm
-0.038 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(BCR\055ABL1\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 441.255 885.529 Tm
-0.179 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\230\222) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 481.755 885.529 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 806.284 Tm
-0.067 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(Chronic\040myeloid\040leukemia\054\040BCR\055ABL1) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 534.855 806.284 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\231) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 545.865 806.284 Tm
-0.049 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(positive) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 621.465 806.284 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\212) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 641.625 806.284 Tm
-0.032 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(CML\054\040BCR\055ABL1\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 799.89 806.284 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\215) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 820.229 806.284 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 727.084 Tm
-0.081 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\223\222\232\222\233\234\235\225\203\226) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 378.255 727.084 Tm
-0.08 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 647.884 Tm
-0.063 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(Chronic\040neutrophilic\040leukaemia) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 476.715 647.884 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\212) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 496.875 647.884 Tm
0.03 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(CNL) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 537.375 647.884 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\215) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 557.745 647.884 Tm
-0.08 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 568.654 Tm
-0.078 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
<9e929f9c9d90a0a1> Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 337.755 568.654 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 489.634 Tm
-0.108 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(Polycythemia\040vera) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 350.895 489.634 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\212) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 371.235 489.634 Tm
-0.028 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(PV) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 397.335 489.634 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\215) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 417.674 489.634 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 410.434 Tm
-0.078 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\242\243\222\216\217\244\245\246) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 337.755 410.434 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 331.234 Tm
-0.034 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(Primary\040myelofibrosis\050PMF\051\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 251.989 Tm
-0.076 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\242\243\222\216\217\244\245\246\227\244\245\246\247) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 439.094 251.989 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\057) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 447.734 251.989 Tm
-0.179 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\250\251) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 488.234 251.989 Tm
-0.26 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\040\040) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 175.53 172.789 Tm
-0.032 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(Primary\040myelofibrosis) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 385.454 172.789 Tm
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(\227) Tj
T*
ET
BT
1 0 0 1 0 0 Tm
1 0 0 1 405.794 172.789 Tm
-0.072 Tc
0.086275 0.086275 0.086275 rg
/F4+0 20.34 Tf
24.408 TL
(prefibrotic\057early\040stage\040\040) Tj
T*
ET
Q
q
0 0 595.2756 841.8898 re
W
n
1 0 0 1 0 0 cm
BT
/F187e976cd-0328-4a1a-9568-d8374593fa13 12 Tf
14.4 TL
ET
BT
1 0 0 1 74.41 37.86 Tm
/F2+072ad28c0-6099-4a1c-a3f1-965855bcecdb 16 Tf
19.2 TL
(2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2141\215) Tj
T*
ET
BT
1 0 0 1 74.41 1224.14 Tm
/F2+072ad28c0-6099-4a1c-a3f1-965855bcecdb 16 Tf
19.2 TL
(2016\200\201WHO\202\203\204\205\206\207\210\211\212\213\040\055\055\2141\215) Tj
T*
ET
Q
endstream
endobj
10 0 obj
<>
endobj
11 0 obj
<>
endobj
12 0 obj
<>
endobj
13 0 obj
<>stream
xUMh\U:f)#&Mfڴ MNDaf=&ҸAA-.,&Eԥ.u).uU:~e4 tB}wy=uX_s]馥I|/ ϿؑcQ\
dڲ͑)aR!y@\q
?A>\ssQJ/b1`Ws>[ZVVklK7Nuq
&39Z4#B
)24LhT"p[fPXbox\_|
>h=j'x>}؏be}z\9mZk/#My)
NτΝY
2Aj?nnƟ=uӇeGZ=
s`G %0jD=-lF-]MinDS
!ɉS7܌
n݅on_7z;̘--GEWv?
%줡։!FrH(>9Ƈ
$:bQ`RDxIa)=dgç$>stream
xeˊpOeK>"f/8jQxdJۀ
D>q.Cc5/릟6M{ܝrLO//nܯw٬~?[|}Zlcq2:qӿ8ïnj27n}r5ӿsm=eneۍ̮ͬ擮_s&zw^xytO-lA+[6@';.5}þA߲ow;=~@?O? ////////+
ү+
ү+
ү+
ү+
ү+
ү+
ү+
үoooooooo;;;;;;;;' ҟ' ҟ' ҟ' ҟ' ҟ' ҟ' ҟ' ҟ_______Y`+m4M<&gw9oG;
endstream
endobj
15 0 obj
<>
endobj
16 0 obj
<>
endobj
17 0 obj
<>stream
xz
X\յ^9p`90d!3a( B !X@ 4&@"j*Ijkbgknz9%Un}*^zm5Z4i]$Fk_wf^k>kk7!Idi՚@wH%;z<#ʱ.l!f,'6tAdUhnw~y@Ow2{` 's3w7o]ߑ'ok(d|¶}!w{n>Ln%dw~BaѨB1L-ըea`0j˛ǎ\#?#"?8'8 G2i'ѷ9PjB,CJ?+B+J-=j$I2$k9NҚ\>d.`@R[?`QqhEQ,&o(It1;p+jܨ!U|Xv:#3=52@ɋdǮybmR^%ABGd9fRFr?>}&h9AN#^^H~KNxLߴ"
W-|~aϓ'q?Ay_u5+r%A=_ǁh 'C Q64\PnYmUhŒ_++yo'-ffRSj1dcAjԼc U5dT{Q24άHr{Lb(VT~X$kS(F$EF
8xK8/~=]Rns#߆cԪV%1^..w]Єt+NY.VZ&ߍ DmX7JWmm_&I܉_QCJUDDlm&S.Q1e6zQ(_A|j6yj6Fbt&Q8,7B*B7HWuUnB :=RSa (c)e& gвI!Fa峞=vvı_%BhDv{&<]hd%EJkhZ$|XH]TxbM8mSM9zWOw <اj=k$_JBs5"m+JQkzݴF'p5|NV$pl7.R!JCױ7Z# Uv6Q7uelww+Kݣ,
UTMOk[kz<5X[JӁ5TĎ.>.2v|&?.?}?